Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Change in Receivables (2016 - 2020)

Glucotrack's Change in Receivables history spans 6 years, with the latest figure at -$10437.0 for Q4 2020.

  • For the quarter ending Q4 2020, Change in Receivables fell 127.31% year-over-year to -$10437.0, compared with a TTM value of -$10000.0 through Dec 2020, down 122.73%, and an annual FY2021 reading of -$68000.0, down 580.0% over the prior year.
  • Change in Receivables for Q4 2020 was -$10437.0 at Glucotrack, down from $397.0 in the prior quarter.
  • The five-year high for Change in Receivables was $38223.0 in Q4 2019, with the low at -$94897.0 in Q4 2018.
  • Average Change in Receivables over 5 years is $806.47, with a median of $526.0 recorded in 2017.
  • Biggest YoY gain for Change in Receivables was 1323.28% in 2018; the steepest drop was 18141.25% in 2018.
  • Tracing GCTK's Change in Receivables over 5 years: stood at $303.0 in 2016, then surged by 73.6% to $526.0 in 2017, then tumbled by 18141.25% to -$94897.0 in 2018, then surged by 140.28% to $38223.0 in 2019, then crashed by 127.31% to -$10437.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Change in Receivables are -$10437.0 (Q4 2020), $397.0 (Q3 2020), and -$1960.0 (Q2 2020).